Vitamin D3 inhibits expression of bullous pemphigoid antigen 1 through post-transcriptional mechanism without new protein synthesis

Journal of Dermatological Science

Volumn 50, Issue 2, 2008, Pages 155-158

  Yamamoto, Chiaki ^a   Tamai, Katsuto ^a   Nakano, Hajime ^a   Matsuzaki, Yasushi ^a   Kaneko, Takahide ^a   Sawamura, Daisuke ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Basement membrane zone; Gene; Keratinocyte; Promoter

Indexed keywords

BULLOUS PEMPHIGOID ANTIGEN 1; COLECALCIFEROL; CYCLOHEXIMIDE; MESSENGER RNA;

CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCUBATION TIME; KERATINOCYTE; LETTER; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CARRIER PROTEINS; CELLS, CULTURED; CHOLECALCIFEROL; CYTOSKELETAL PROTEINS; DOWN-REGULATION; HUMANS; KERATINOCYTES; NERVE TISSUE PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TRANSFECTION;

EID: 41149181270     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.12.003     Document Type: Letter

References (10)

1. Hashimoto T. Skin diseases related to abnormality in desmosomes and hemidesmosomes-editorial review. J Dermatol Sci 20 (1999) 81-84
2. Yoshida M., Hamada T., Amagai M., Hashimoto K., Uehara R., Yamaguchi K., et al. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci 41 (2006) 21-30
3. Tsuji-Abe Y., Akiyama M., Yamanaka Y., Kikuchi T., Sato-Matsumura K.C., and Shimizu H. Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid. J Dermatol Sci 37 (2005) 145-149
4. Tanaka T., Parry D.A., Klaus-Kovtun V., Steinert P.M., and Stanley J.R. Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem 266 (1991) 12555-12559
5. Nagpal S., Lu J., and Boehm M.F. Vitamin D analogs: mechanism of action and therapeutic applications. Curr Med Chem 8 (2001) 1661-1679
6. Tamai K., Li K., Silos S., Rudnicka L., Hashimoto T., Nishikawa T., et al. Interferon-γ-mediated inactivation of transcription of the 230-kDa bullous pemphigoid antigen gene (BPAG1) provides novel insight into keratinocyte differentiation. J Biol Chem 270 (1995) 392-396
7. Ken Harada, Katsuto Tamai, Hajime Nakano, Yamamoto C., Hanada K., et al. Inhibitory effect of TGF-β on expression of 230 kD bullous pemphigoid antigen. Hirosaki Med J 59 (2007) 7-14
8. Liu Z., Diaz L.A., Troy J.L., Taylor A.F., Emery D.J., Fairley J.A., et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92 (1993) 2480-2488
9. Nishie W., Sawamura D., Goto M., Ito K., Shibaki A., McMillan J.R., et al. Humanization of autoantigen. Nat Med 14 (2007) 378-383
10. Kohroh K., Suga Y., Mizuno Y., Ishii N., Hashimoto T., and Ikeda S. Case of localized bullous pemphigoid with unique clinical manifestations in the lower legs. J Dermatol 34 (2007) 482-485